World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 11 April 2016
Main ID:  NCT02390648
Date of registration: 11/03/2015
Prospective Registration: No
Primary sponsor: Mahidol University
Public title: Efficacy of Ginger as an Adjunctive Prophylaxis for Chemotherapy-induced Nausea and Vomiting
Scientific title: Efficacy of Ginger as an Adjunctive Prophylaxis for Chemotherapy-induced Nausea and Vomiting: Randomised Double-blind Placebo-control Cross Over Study
Date of first enrolment: March 2015
Target sample size: 34
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02390648
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care  
Phase:  Phase 2
Countries of recruitment
Thailand
Contacts
Name:     Nopadol Soparattanapaisarn, MD
Address: 
Telephone:
Email:
Affiliation:  Lecturer
Key inclusion & exclusion criteria

Inclusion Criteria:

- Histologically or cytologically confirmed breast cancer patient

- Received AC regimen chemotherapy (Doxorubicin + Cyclophosphamide) and has nausea
score at least 40/100 VAS or has vomiting

- Expect to receive at least 2 further cycles of AC regimen chemotherapy

- Provide informed consent

Exclusion Criteria:

- Pregnancy or lactation

- Has nausea or vomiting during 24 hours before chemotherapy

- Has other causes of nausea or vomiting eg. brain metastasis, gut obstruction,
hepatitis or recent abdominal or pelvic irradiation within 1 week before chemotherapy

- Received any chemotherapy regimen other than AC regimen

- Allergic or intolerance to ginger



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Chemotherapy-induced Nausea and Vomiting
Intervention(s)
Drug: Ginger
Drug: Placebo
Primary Outcome(s)
Nausea score [Time Frame: The first 5 days of chemotherapy cycle]
Secondary Outcome(s)
Secondary ID(s)
732/2557(EC1)
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history